Clinical efficacy and toxic reaction of Tegafur, Gimeracil and Oteracil Potassium combined with Gemcitabine for patients with radical resection for advanced gallbladder carcinoma
10.3760/cma.j.issn.1007-8118.2018.01.007
- VernacularTitle:进展期胆囊癌患者术后应用替吉奥联合吉西他滨的临床疗效
- Author:
Zhen SUN
1
;
Penglei GE
;
Zhiqiang GAO
;
Haokun LIU
;
Yang WU
;
Zhe TANG
Author Information
1. 450000,郑州大学第一附属医院肝胆胰外科
- Keywords:
Advanced gallbladder carcinoma;
Radical resection of gallbladder carcinoma;
Tegafur,Gimeracil and Oteracil Potassium Capsule;
Gemcitabine;
5-Fluorouracil;
Oxaliplatin
- From:
Chinese Journal of Hepatobiliary Surgery
2018;24(1):29-33
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the clinical efficacy and toxic reaction of Tegafur,Gimeraciland Oteracil Potassium Capsule combined with Gemcitabine chemotherapy for patients with radical resection for advanced gallbladder carcinoma.Methods The clinical dataof 135 patients with advanced gallbladder cancer who were admitted to the 1 st Affiliated Hospital of Zhengzhou University and supported after the gastrectomy by the pathology from June 2007 to June 2012 were retrospectively analyzed.All patients were divided into three groups by different therapeutic regimens,operation groups (Radical resection or Extended radical resection of gallbladder carcinoma) with 47 cases,chemotherapy A group (Tegafur,Gimeracil and Oteracil Potassium Capsule combined with Gemcitabine chemotherapy after Radical resection or Extended radical resection of gallbladder carcinoma) with 52 cases,and chemotherapy B group (5-Fluorouracil combined with Oxaliplatin chemotherapy after Radical resection or Extended radical resection of gallbladder carcinoma) with 36 cases.We collected the dates of all patients with the median survival time and the 1,3 and 5-year survival rate after operation,and counted the rate of major toxic reaction after chemotherapy.Results There were no significant differences in the general date of three groups (sex,age,tumor size,CA19-9,CA125,TNM stages,with or without cholecystolithiasis,operation methods,operation complication),The chemotherapy A group and chemotherapy B group had no differenceswiththe median survival time and 1,3 and 5-year survival rate after operation.There were significant differences in the median survival time and 3,5-year survival rate after operation between the operation group and chemotherapy A group (or between the operation group and chemotherapy B group).There were significant differences in the rate of whole toxic reaction and the rate of toxic reaction beyond Ⅲ degree between chemotherapy A group and chemotherapy B group.Conclusions The treatment of Tegafur,Gimeracil and Oteracil Potassium Capsule combined with Gemcitabine chemotherapy for patients with radical resection of advanced gallbladder carcinoma has a lower rate of whole toxic reaction and rate of toxic reaction beyond Ⅲ degree than 5-Fluorouracil combined with Oxaliplatin chemotherapy,and for patients with advanced gallbladder carcinoma,the frontal treatment can obviously prolong the median survival time and effectively improve the 3 and 5-year survival rate after operation.
